# Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

> **NCT05458856** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 147 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Triptorelin embonate 22.5 mg

## Key facts

- **NCT ID:** NCT05458856
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-30
- **Primary completion:** 2024-07-08
- **Final completion:** 2024-07-08
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458856, "Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05458856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*